Their Objective
Scaling Meta Ad Performance While Staying Privacy Compliant
AgelessRx, a fast-growing telehealth platform, ran into critical challenges such as:
- Weak EMQ signal (~5), limiting Meta’s optimization effectiveness
- Duplicate events from disconnected server and client data, which hurt attribution accuracy
- Delays in creative testing due to inconsistent signal reliability
- Needing to future-proof against Meta’s evolving privacy and compliance requirements
“Even before Meta’s new health restrictions, we had a signal strength problem. Meta’s CAPI helped, but it wasn’t unified. That’s where Blotout came in.”
The Solution
Laying the Foundation for Scalable, Privacy-Compliant Growth
With Blotout’s help, AgelessRx:
- Increased EMQ score from ~5 to 7–8, enabling more efficient Meta delivery
- Improved CAC efficiency by 10–20% through higher-quality targeting and attribution
- Doubled Meta ad spend in Q1 with confidence in performance data
- Moved away from 1-day view attribution, focusing on high-LTV customer segments
The Results
Driving Performance at Scale with Trusted Signal Quality
Within one fiscal quarter of using Blotout, AgelessRx:
- Increased EMQ score from ~5 to 7–8, enabling more efficient Meta delivery
- Improved CAC efficiency by 10–20% through higher-quality targeting and attribution
- Doubled Meta ad spend in Q1 with confidence in performance data
- Moved away from 1-day view attribution, focusing on high-LTV customer segments
'With a unified data foundation and stronger signal integrity, AgelessRx unlocked the scale, efficiency, and confidence needed to grow sustainably on Meta—without compromising on compliance.'
